DCGI
India poised to become 'global hub for medicines': DCGI
New Delhi: There has been a fourfold increase in applications of the investigational new drugs in the country, according to Dr VG Somani, Drug Controller General of India (DCGI), media reports said.
He claimed that India is on course to become a 'global hub for medicines', said an ANI report.
"We are getting the applications of the investigational new drugs. Earlier, there used to be hardly 5-10 applications. At present, there are 23 applications in the pipeline for the investigational new drug and this is a great achievement of our country," Somani was quoted as saying by ANI.
The DCGI official also explained how drug controllers work while taking decisions about vaccines and drugs.
"We have been in regular contact with the WHO and all regulators of the world through ICMR, ICH platform etc. There are various platforms for the approval of vaccines and drugs including trials. That's what we have done with remdesivir. There is no single platform for decisions to be taken," Somani said.
He said Indis has been already recognised as "Pharmacy of the world" and added "we want to become the well-managed pharmacy of the entire world so that our potential can be recognised", according to the ANI report.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
